If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
218.00    7.50 (3.56%)
Bid:
217.50
Ask:
218.50
Spread: 1.00 (0.46%)
Market Cap: £580.16m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

A303 Delivery Assurance Partnership

30 Sep 2022 14:32

RNS Number : 4010B
Costain Group PLC
30 September 2022
 

 

Costain Group PLC

30 September 2022

 

 

Costain Joint Venture Wins A303 Delivery Assurance Partnership

 

Costain announces that National Highways has appointed a Costain and Mott MacDonald joint venture as Delivery Assurance Partner for the A303 Stonehenge Improvements Scheme. In this consultancy role, Costain and its partner will manage the design and construction by the main contractor of a new dual carriageway and tunnel, replacing the existing single carriage road. 

 

The joint venture, as part of the National Highways integrated project team, will collaborate with the customer, main contractor, supply chain, road users and the local community to ensure the effective design and delivery of the A303 improvement works.

 

Sue Kershaw, managing director for Transportation, Costain, commented:"This award demonstrates Costain's growing consultancy position as an established delivery assurance partner; where together with our customers we will be creating connected, sustainable infrastructure that helps people and the planet to thrive. This is the second award for our Costain Mott MacDonald partnership and demonstrates the delivery of our strategy in meeting the wider needs of our customers."

 

Ken Norbury, transportation managing director, Mott MacDonald said: "We have assembled a world class multidisciplinary team to support the delivery of this vital upgrade project. We are proud to be chosen alongside Costain and look forward to working collaboratively with the project team."

 

Derek Parody, National Highways' Project Director for the A303 Stonehenge scheme, said: "We're pleased we have completed the procurement process, and once the redetermination process is finalised, and should the Development Consent Order be granted, having this expertise in place will put us in the strongest possible position to deliver this transformational scheme and deliver the benefits we know it can."

 

Once complete, the scheme will significantly improve the lives of people living in and travelling through the area, enhance the Stonehenge World Heritage site and the setting of the stones, while bringing economic and environmental benefits by reducing congestion and increasing biodiversity.

 

 

 

Enquiries

 

Investors and analysts

paul.sharma@costain.com

Paul Sharma

+44 (0) 7867 501188

 

 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997 365

 

Notes to editors

 

Costain helps to improve people's lives by creating connected, sustainable infrastructure that enables people and the planet thrive. We shape, create and deliver pioneering solutions that transform the performance of the infrastructure ecosystem across the UK's transport, energy, water, and defence markets.

 

We are organised around our customers anticipating and solving their challenges and helping to improve performance. By bringing together our unique mix of construction, consulting and digital experts we engineer and deliver sustainable, efficient and practical solutions.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKKBBNBKDCCN
Date   Source Headline
1st Jul 202610:30 amRNSTransaction in Own Shares
1st Jul 20269:30 amRNSBlock Listing Interim Review
1st Jul 20269:25 amRNSTotal Voting Rights
25th Jun 202610:25 amRNSDirector/PDMR Shareholding
24th Jun 202610:30 amRNSTransaction in Own Shares
23rd Jun 202610:11 amRNSDirector/PDMR Shareholding
18th Jun 202611:46 amRNSDirector/PDMR Shareholding
18th Jun 20267:00 amRNS-RCostain wins West Winch Housing Road contract
17th Jun 202610:30 amRNSTransaction in Own Shares
10th Jun 20269:27 amRNSTransaction in Own Shares
9th Jun 20263:25 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSCostain wins place on £700m TfL framework
3rd Jun 202610:30 amRNSTransaction in Own Shares
1st Jun 202610:31 amRNSTotal Voting Rights
27th May 20269:34 amRNSTransaction in Own Shares
22nd May 20261:00 pmRNSDirector/PDMR Shareholding
20th May 20269:55 amRNSTransaction in Own Shares
18th May 20261:51 pmRNSAdditional Listing
18th May 20269:39 amRNSDirector Declaration
14th May 20264:28 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
13th May 20265:14 pmRNSHolding(s) in Company
13th May 202610:19 amRNSTransaction in Own Shares
12th May 20264:01 pmRNSHolding(s) in Company
6th May 20269:35 amRNSTransaction in Own Shares
5th May 20262:08 pmRNSDirector/PDMR Shareholding
1st May 20264:08 pmRNSScrip Dividend Reference Price - Replacement
1st May 20269:08 amRNSTotal Voting Rights
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
29th Apr 202610:14 amRNSTransaction in Own Shares
27th Apr 202612:27 pmRNSScrip Dividend Reference Price
22nd Apr 20265:06 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:48 amRNSTransaction in Own Shares
21st Apr 20265:15 pmRNSHolding(s) in Company
16th Apr 20264:59 pmRNSHolding(s) in Company
15th Apr 20263:16 pmRNSTransaction in Own Shares
15th Apr 20263:05 pmRNSDirector/PDMR Shareholding
14th Apr 20263:29 pmRNSDirector Declaration
13th Apr 202611:20 amRNSDirector/PDMR Shareholding
8th Apr 202610:30 amRNSTransaction in Own Shares
2nd Apr 202611:19 amRNSAnnual Financial Report
1st Apr 202610:30 amRNSTransaction in Own Shares
1st Apr 20269:30 amRNSDirector/PDMR Shareholding
1st Apr 20268:59 amRNSTotal Voting Rights
27th Mar 20263:35 pmRNSAdditional Listing
25th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNS-RCostain Secures c.£45m Contract with Severn Trent
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:01 amRNS£20m Share Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.